Stay updated on Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.

Latest updates to the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.3.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1.0%
- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed inclusion and exclusion criteria for a clinical study on Beta Thalassemia Major, while a new revision number has been added.SummaryDifference26%
- Check67 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check75 days agoChange DetectedThe web page has been updated to a new version, v2.14.3, replacing the previous version v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.